Global NeuN Antibody Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Table of Contents
1 Market Overview of NeuN Antibody
- 1.1 NeuN Antibody Market Overview
- 1.1.1 NeuN Antibody Product Scope
- 1.1.2 NeuN Antibody Market Status and Outlook
- 1.2 Global NeuN Antibody Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global NeuN Antibody Market Size by Region (2016-2027)
- 1.4 Global NeuN Antibody Historic Market Size by Region (2016-2021)
- 1.5 Global NeuN Antibody Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, NeuN Antibody Market Size (2016-2027)
- 1.6.1 North America NeuN Antibody Market Size (2016-2027)
- 1.6.2 Europe NeuN Antibody Market Size (2016-2027)
- 1.6.3 Asia-Pacific NeuN Antibody Market Size (2016-2027)
- 1.6.4 Latin America NeuN Antibody Market Size (2016-2027)
- 1.6.5 Middle East & Africa NeuN Antibody Market Size (2016-2027)
2 NeuN Antibody Market Overview by Type
- 2.1 Global NeuN Antibody Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global NeuN Antibody Historic Market Size by Type (2016-2021)
- 2.3 Global NeuN Antibody Forecasted Market Size by Type (2022-2027)
- 2.4 Polyclonal
- 2.5 Monoclonal
3 NeuN Antibody Market Overview by Application
- 3.1 Global NeuN Antibody Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global NeuN Antibody Historic Market Size by Application (2016-2021)
- 3.3 Global NeuN Antibody Forecasted Market Size by Application (2022-2027)
- 3.4 Immunocytochemistry
- 3.5 Immunofluorescence
- 3.6 Immunohistochemistry
- 3.7 Western Blot
- 3.8 Others
4 NeuN Antibody Competition Analysis by Players
- 4.1 Global NeuN Antibody Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NeuN Antibody as of 2020)
- 4.3 Date of Key Players Enter into NeuN Antibody Market
- 4.4 Global Top Players NeuN Antibody Headquarters and Area Served
- 4.5 Key Players NeuN Antibody Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 NeuN Antibody Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Boster Biological Technology
- 5.1.1 Boster Biological Technology Profile
- 5.1.2 Boster Biological Technology Main Business
- 5.1.3 Boster Biological Technology NeuN Antibody Products, Services and Solutions
- 5.1.4 Boster Biological Technology NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.1.5 Boster Biological Technology Recent Developments
- 5.2 Thermo Fisher Scientific
- 5.2.1 Thermo Fisher Scientific Profile
- 5.2.2 Thermo Fisher Scientific Main Business
- 5.2.3 Thermo Fisher Scientific NeuN Antibody Products, Services and Solutions
- 5.2.4 Thermo Fisher Scientific NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.2.5 Thermo Fisher Scientific Recent Developments
- 5.3 Abcam
- 5.3.1 Abcam Profile
- 5.3.2 Abcam Main Business
- 5.3.3 Abcam NeuN Antibody Products, Services and Solutions
- 5.3.4 Abcam NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.3.5 HUABIO Recent Developments
- 5.4 HUABIO
- 5.4.1 HUABIO Profile
- 5.4.2 HUABIO Main Business
- 5.4.3 HUABIO NeuN Antibody Products, Services and Solutions
- 5.4.4 HUABIO NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.4.5 HUABIO Recent Developments
- 5.5 Synaptic
- 5.5.1 Synaptic Profile
- 5.5.2 Synaptic Main Business
- 5.5.3 Synaptic NeuN Antibody Products, Services and Solutions
- 5.5.4 Synaptic NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.5.5 Synaptic Recent Developments
- 5.6 GeneTex
- 5.6.1 GeneTex Profile
- 5.6.2 GeneTex Main Business
- 5.6.3 GeneTex NeuN Antibody Products, Services and Solutions
- 5.6.4 GeneTex NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.6.5 GeneTex Recent Developments
- 5.7 BioLegend
- 5.7.1 BioLegend Profile
- 5.7.2 BioLegend Main Business
- 5.7.3 BioLegend NeuN Antibody Products, Services and Solutions
- 5.7.4 BioLegend NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.7.5 BioLegend Recent Developments
- 5.8 Merck
- 5.8.1 Merck Profile
- 5.8.2 Merck Main Business
- 5.8.3 Merck NeuN Antibody Products, Services and Solutions
- 5.8.4 Merck NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.8.5 Merck Recent Developments
- 5.9 NSJ Bioreagents
- 5.9.1 NSJ Bioreagents Profile
- 5.9.2 NSJ Bioreagents Main Business
- 5.9.3 NSJ Bioreagents NeuN Antibody Products, Services and Solutions
- 5.9.4 NSJ Bioreagents NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.9.5 NSJ Bioreagents Recent Developments
- 5.10 Bioss
- 5.10.1 Bioss Profile
- 5.10.2 Bioss Main Business
- 5.10.3 Bioss NeuN Antibody Products, Services and Solutions
- 5.10.4 Bioss NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.10.5 Bioss Recent Developments
- 5.11 Miltenyi Biotec
- 5.11.1 Miltenyi Biotec Profile
- 5.11.2 Miltenyi Biotec Main Business
- 5.11.3 Miltenyi Biotec NeuN Antibody Products, Services and Solutions
- 5.11.4 Miltenyi Biotec NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.11.5 Miltenyi Biotec Recent Developments
- 5.12 United States Biological
- 5.12.1 United States Biological Profile
- 5.12.2 United States Biological Main Business
- 5.12.3 United States Biological NeuN Antibody Products, Services and Solutions
- 5.12.4 United States Biological NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.12.5 United States Biological Recent Developments
- 5.13 Proteintech
- 5.13.1 Proteintech Profile
- 5.13.2 Proteintech Main Business
- 5.13.3 Proteintech NeuN Antibody Products, Services and Solutions
- 5.13.4 Proteintech NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.13.5 Proteintech Recent Developments
- 5.14 FineTest
- 5.14.1 FineTest Profile
- 5.14.2 FineTest Main Business
- 5.14.3 FineTest NeuN Antibody Products, Services and Solutions
- 5.14.4 FineTest NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.14.5 FineTest Recent Developments
- 5.15 Cell Signaling Technology
- 5.15.1 Cell Signaling Technology Profile
- 5.15.2 Cell Signaling Technology Main Business
- 5.15.3 Cell Signaling Technology NeuN Antibody Products, Services and Solutions
- 5.15.4 Cell Signaling Technology NeuN Antibody Revenue (US$ Million) & (2016-2021)
- 5.15.5 Cell Signaling Technology Recent Developments
6 North America
- 6.1 North America NeuN Antibody Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe NeuN Antibody Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific NeuN Antibody Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America NeuN Antibody Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa NeuN Antibody Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 NeuN Antibody Market Dynamics
- 11.1 NeuN Antibody Industry Trends
- 11.2 NeuN Antibody Market Drivers
- 11.3 NeuN Antibody Market Challenges
- 11.4 NeuN Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Market Insights
QY Research has lately published a report titled “Global NeuN Antibody Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global NeuN Antibody market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Polyclonal
Monoclonal
Segment by Application
Immunocytochemistry
Immunofluorescence
Immunohistochemistry
Western Blot
Others
Regional Scope
This segment of the report offers a thorough regional study of the global NeuN Antibody market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Boster Biological Technology
Thermo Fisher Scientific
Abcam
HUABIO
Synaptic
GeneTex
BioLegend
Merck
NSJ Bioreagents
Bioss
Miltenyi Biotec
United States Biological
Proteintech
FineTest
Cell Signaling Technology
Frequently Asked Questions
Which application segment captured the leading share in the NeuN Antibody market?
How fragmented is the NeuN Antibody market?
Which are the key growth drivers in the NeuN Antibody market?
Which are the top strategies undertaken by the NeuN Antibody market players?
Which technological trends are likely to affect the NeuN Antibody market?
What is the expected NeuN Antibody market size by 2027?
Which companies are dominating the NeuN Antibody market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the NeuN Antibody market growth?
Which are the emerging companies in the NeuN Antibody market?